Aster DM Healthcare Limited

97%

harmacies (UAE) 2015: First clinic in Bahrain and in the Philippines 2016: Increased stake up to 97% in Sanad Medical Care (KSA) 2016: Medcare Women and Children Hospital (UAE) 2017: Medcare Hospi

INR 3,215

: 1 Hospital | 6 Pharmacies | 24 PEC’s Largest Number of Medical Centers/Polyclinics in the GCC INR 3,215 Cr (2,662 Cr) Revenue6 GCC : INR 2,377 Cr (2,011 Cr) India : INR 838 Cr (651 Cr) One of the Larges

INR 2,377

Largest Number of Medical Centers/Polyclinics in the GCC INR 3,215 Cr (2,662 Cr) Revenue6 GCC : INR 2,377 Cr (2,011 Cr) India : INR 838 Cr (651 Cr) One of the Largest Chain of Pharmacies in the UAE 31,222

INR 838

ers/Polyclinics in the GCC INR 3,215 Cr (2,662 Cr) Revenue6 GCC : INR 2,377 Cr (2,011 Cr) India : INR 838 Cr (651 Cr) One of the Largest Chain of Pharmacies in the UAE 31,222* (27,242) Human Resources D

rs7

651 Cr) One of the Largest Chain of Pharmacies in the UAE 31,222* (27,242) Human Resources Doctors7 : 3,998 : 9,204 Nurses Others8 : 13,696 Outsourced8 : 4,324 Notes: 1. Count includes 3 O&M Asset

rs8

n of Pharmacies in the UAE 31,222* (27,242) Human Resources Doctors7 : 3,998 : 9,204 Nurses Others8 : 13,696 Outsourced8 : 4,324 Notes: 1. Count includes 3 O&M Asset Light Hospitals with a capacity

rs 8

the nearest integer 7. India patient visit count excludes pharmacy and lab visits Full-time doctors 8. Other employee count in India includes the count of 569 which is for shared service support to G

rs 181

s 272 Pharmacies H – Hospitals C – Clinics P – Pharmacies L – Labs PEC – Patient Experience Centers 181 Hospitals 12 Clinics 2552 Pharmacies 2293 Labs 1. Count includes 3 O&M Asset Light Hospitals wit

26%

e centers Aster DM Healthcare – Financial Overview Revenue- Q1 FY24 EBITDA- Q1 FY24 India India 26% (PY: XX%) (PY : 24%) GCC GCC 74% (PY: XX%) (PY : 76%) Revenue- Q1 FY24 Pharmacies (PY: XX%) (PY

24%

Healthcare – Financial Overview Revenue- Q1 FY24 EBITDA- Q1 FY24 India India 26% (PY: XX%) (PY : 24%) GCC GCC 74% (PY: XX%) (PY : 76%) Revenue- Q1 FY24 Pharmacies (PY: XX%) (PY : 24%) Clinics (P

74%

inancial Overview Revenue- Q1 FY24 EBITDA- Q1 FY24 India India 26% (PY: XX%) (PY : 24%) GCC GCC 74% (PY: XX%) (PY : 76%) Revenue- Q1 FY24 Pharmacies (PY: XX%) (PY : 24%) Clinics (PY : 20%) (PY:

76%

evenue- Q1 FY24 EBITDA- Q1 FY24 India India 26% (PY: XX%) (PY : 24%) GCC GCC 74% (PY: XX%) (PY : 76%) Revenue- Q1 FY24 Pharmacies (PY: XX%) (PY : 24%) Clinics (PY : 20%) (PY: XX%) Hospitals (PY

“ Program being scaled up to benefit 2.1 M unique customers across pharmacy, clinics, Hospitals and Medcare  Introduced “telecalling” as a nudge for maternity and HLTV pharmacy patients  Incremental Revenue of INR 38 crore achieved in Q1 –FY24 Aster Labs was established in 2019, WE WILL TREAT YOU WELL is the brand promise that every analysis will be most accurate, and help doctors to diagnose better and ultimately help patients recover faster.”

“Target is to also offer Molecular Diagnostics and High end & advanced tests in future.”

“We expect this to yield significant gains to business in the coming years India Strategy Aster DM Healthcare hopes to leverage its extensive experience of working in a 100% insurance market in the GCC to derive better margins due to the increasing share of Insurance segment in the Indian market The current central government has focused significantly on continuous reformation that impacts the health sector.”

Notes

5

Note

3

Source

1

Notes

1. Count includes 3 O&M Asset Light Hospitals with a capacity of 390 beds 2. GCC Retail Pharmacies includes Opticals 3. Pharmacies in India operated by ARPPL under brand license from Aster 4. As on 30th June 2023, India has 1 reference lab, 14 satellite labs, 214 Patient Experience Centers (PEC) 5. 6. Revenue shown above excludes other income; Financial numbers are rounded to the nearest integer 7. India patient visit count excludes pharmacy and lab visits Full-time doctors 8. Other employee count in India includes the count of 569 which is for shared service support to GCC. Outsourced employee count in India includes the count of 31 which is for shared service support to GCC 9. Numbers in brackets () are for FY23 Q1 *GCC: Doctors: 1,613 Nurses: 3,640 Others: 6,144 Outsourced : 1,315 India: Doctors: 2,385 Nurses: 5,564 Others: 7,552 Outsourced : 3,009 Geographical Footprint 6 United Arab Emirates H(9) C(101) P(249) Kingdom of Saudi Arabia H(1) Kerala Andhra Pradesh H(6) C(2) P(86) L(5)

Note

1. 2. 3. 4. 5. Revenue and EBITDA shown above excludes other income Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated corporate overheads All the numbers above are post IndAS 116 Percentages in bracket represent revenue and EBITDA for PY – Previous Year India Clinics which was previously classified under Hospitals, is now included under Clinics 6. Wholesale Pharmacy which was previously classified under Hospitals, is now included under Pharmacies India Labs are being classified under Hospitals 7. 8. Numbers in brackets are for Q1 FY23 GCC Hospitals UAE Aster Hospital Mankhool Dubai CB:140 OB:118 2015, Leased Aster Hospital Qusais Dubai CB:157 OB:126 2018, Leased Cedars Hospital Dubai CB:20 OB:12 2019, Leased Aster Hospital Sonapur Dubai CB:35 OB:25 2020, Leased Medcare Hospital Dubai CB:64 OB:55 2007, Leased Medcare Orthopaedics and Spine Hospital D

Note

1. Out-Patient visits mentioned above does not include pharmacy visits FY22 Outpatient count includes 3.3 mn relating to Covid testing 2. Capacity beds shown above excludes O&M beds of WIMS hospital which was included in bed count in the previous presentations 3. FY21 numbers have an impact of COVID 4. Pharmacies in India operated by ARPPL under brand license from Aster 5. As on 30th June 2023, India has 1 reference lab, 14 satellite labs, 214 patient experience centers (PEC) 6. 7. Hospital count includes 3 O&M Asset Light Hospitals with a capacity of 390 beds FY24 Q1 33 127 272 255 229 916 AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider Aster - An Integrated Healthcare Provider FY23 Operational Information ~5.1 mn Clinic OPD Visits ~ 9.8 mn Pharmacy Visits ~ 4.7 mn Hospital OPD visits 326,300+ IP Discharges 22,800+ General Surgeries 4,000+ Joint Replacements 17,700+ Urology Cases 25,200+ Deliveries 9,300+ Gastro-Intestinal Surgeries 1,800+ Cardiovascular Su

Note

*Transplants includes kidney, heart, liver, pancreas, etc. Aster – A Healthcare Ecosystem Patient Life Cycle Management Hospitals Clinics Pharmacies GCC INDIA • Indian operations act as a source of talent (Doctors, Nurses, and other employees) to GCC operations • Within GCC operations, Clinic Doctors have the opportunity to hone their surgical skills in Aster’s Hospitals • Aster, over 35 years, has created a Healthcare Ecosystem across two geographical regions • In GCC region, Aster’s Primary Care Clinics act as the initial touchpoints in the patients' journey, while Pharmacies and Hospitals continue the care • For complex Tertiary Care, patients are transferred to Aster’s Hospitals in India Hospitals Clinics Resource Talent Management Digital Health Currently ranks #1 among the Free Apps in Medical Category in the UAE Virtual Care – Omni-channel experience for Patients  Influx of 270K unique users (6% growth over Q4 FY23) and 700K sessions (15% growth over Q4 FY23)  In-person appoin

Source

1. english.alarabiya.net 2. worldpopulationreview.com 3. 4. omanobserver.com edsfze.com Healthcare market in GCC states, which is mostly insurance driven, have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector)  Due to lower % of older population, requirement of tertiary and quaternary care is relatively limited  Due to lack of support systems (family, relatives, etc.) expat community travel back to their home countries for major health concerns  Hence private healthcare delivery is focused on primary and secondary healthcare  Recently there has been a trend towards selective tertiary care focus in UAE, however this will remain proportionately lower  Only Saudi Arabia, with its sizeable population of nationals is suitable for tertiary and quaternary care facilities Seasonality of Patient Volumes  Decline in volumes across hospitals, pharmacies and segments during the summer

Notes

1. Above financials are presented in INR Crore and post IndAS 116 2. Percentages mentioned inside the bars are % to revenue excluding other income 3. Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is 15%, 27% and -90% respectively 4. Aster Royal Hospital Muscat, Aster Narayanadri Tirupati, Aster G Madegowda Mandya and Ramesh (IB) Vijayawada are classified as new hospitals. 5. Reported PAT and Adjusted PAT are Post Non-Controlling Interest. Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY23 Q1 FY24 Q1 Gw (%) FY23 Q1 FY24 Q1 Gw (%) FY23 Q1 FY24 Q1 Gw (%) Revenue (₹) EBITDA (₹) PAT (₹) Adjusted PAT (₹) NM  Excluding New Hospitals and non-recurring costs: Revenue, EBITDA and PAT (post – NCI) for GCC are Rs. 2,320 Crs (growth of 15%), Rs. 280 Crs (growth of 34%) & Rs. 41 Crs (growth of 57%) respectively  High margin Covid Testing Revenue of INR 63 crs in FY23 Q1 has been replaced by core healthcare revenue, which has grown by 22% YoY  Excluding